New diabetes clinical trial: Treatment of GLP-1 for Diabetic Bariatric Patients

Published on: November 11, 2020 at 10:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide (1 Mg Dose);   Drug: Placebo
Sponsors:   Geisinger Clinic;   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/2GUPaLl